AMPE
Ampio Pharmaceuticals Inc.
AMPE
AMPE
Delisted
AMPE was delisted on the 12th of April, 2024.
95 hedge funds and large institutions have $1.77M invested in Ampio Pharmaceuticals Inc. in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 24 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
75% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 20
Holders
95
Holding in Top 10
–
Calls
$62K
Puts
$1K
Top Buyers
| 1 | +$101K | |
| 2 | +$57K | |
| 3 | +$39.8K | |
| 4 |
Two Sigma Advisers
New York
|
+$19.6K |
| 5 |
Man Group
London,
United Kingdom
|
+$11K |
Top Sellers
| 1 | -$161K | |
| 2 | -$111K | |
| 3 | -$73K | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$66K |
| 5 |
ACM
ACT Capital Management
Wayne,
Pennsylvania
|
-$49K |